Bajaj Healthcare Limited enters into CDMO contracts for 15 new APIs

Bajaj Healthcare Limited is entering into a definitive CDMO contract with UK/EU based companies for 15 new APIs. This is in addition to 15 molecules for which we entered the contract with UK/EU based clients on 27th February 2024. The new CDMO pipeline has a mix of, off Patent Generic APIs as well as APIs which are still under patent.

Speaking at the occasion Mr. Anil Jain, Managing Director, Bajaj Healthcare Limited, said "We are delighted to share this development which reinforces the capabilities that we are building in terms of cost-effective route of synthesis in our R&D and the expansion of manufacturing capabilities, mostly at our USFDA, EU and now TGA, Australia approved site located at Block No. 588, SavliKarachiya Road, At & Post: Gothada, Tal. Savli, Dist: Vadodara, Gujarat. The company is likely to enter into few CDMO deals with clients in Australia, New Zealand and South Africa, after the approval of the site by the TGA.

Source : Equity Bulls

Keywords

BajajHealthcare CDMOContract UK EU 15NewAPIs